$0.363
+0.003 (+0.72%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
SLXN Prediction & Forecast by Similar Chart Analysis
Alphio's SLXN stock price prediction model matches the current Silexion Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.36 (-1.02%). The 1-week path is $0.35 (-3.25%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Silexion Therapeutics Corp Stock?
Silexion Therapeutics is not a good buy right now due to its significant financial losses and declining stock performance. The current price is $0.36, with a staggering year-to-date change of -98.07%. Additionally, the company has a negative EPS of -5.17, indicating ongoing losses, and a forward P/E ratio of 0, suggesting no expected earnings growth. The main risk is the potential for further dilution from the recent public offering priced at $0.65 per share, which could further depress the stock price.
SLXN stock price ended at $0.36 on Friday, after rising +0.72%
Silexion Therapeutics Corp (SLXN) last closed at $0.3628, gaining +0.72%. These facts feed the 1-day and 1-week SLXN price prediction above.
Forecast Drivers
Silexion Therapeutics Corp (SLXN) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches SLXN, ranked by similarity.
Seasonality analysis for SLXN
Historically the probability of a positive August return for SLXN is 12.70%. January offers the highest probability of a positive month at 65.57%, while September is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for SLXN
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $0.58 | $0.74 | $0.86 | +103.69% |
| Sep 2026 | $0.92 | $1.00 | $1.08 | +175.58% |
| Oct 2026 | $0.69 | $0.85 | $0.88 | +133.72% |
| Nov 2026 | $0.90 | $0.91 | $1.05 | +151.10% |
| Dec 2026 | $0.81 | $0.92 | $0.95 | +152.56% |
In 2026, Silexion Therapeutics Corp (SLXN) is projected to range from $0.58 to $1.08.
Silexion Therapeutics Corp 2026 monthly forecast
In Aug 2026, Silexion Therapeutics Corp is projected to average $0.74, with a low of $0.58 and high of $0.86.
In Sep 2026, Silexion Therapeutics Corp is projected to average $1.00, with a low of $0.92 and high of $1.08.
In Oct 2026, Silexion Therapeutics Corp is projected to average $0.85, with a low of $0.69 and high of $0.88.
In Nov 2026, Silexion Therapeutics Corp is projected to average $0.91, with a low of $0.90 and high of $1.05.
In Dec 2026, Silexion Therapeutics Corp is projected to average $0.92, with a low of $0.81 and high of $0.95.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.